DEFINITIVE PROXY STATEMENT

Company

ORAMED PHARMACEUTICALS INC.

Filed

June 30, 2020

Period of Report

August 3, 2020

Accession Number

0001213900-20-016305

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →